Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > The drop to $0.325 was the PENSA effect

<< Previous

Bullboard Posts

Next >>

Comment by sweenbyon Oct 21, 2010 12:52pm

255 Views

Post# 17593681

RE: The drop to $0.325 was the PENSA effect

I agree it looks like typical trading pending news. There is still a little time left to play here and looks like the people in the know want in but at what price. Cheaper the better of course. Time will tell and in my opinion it looks good for a run up. glta

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading